Why is the comparison with Medicare for VUITY 1.25% EYE DROP labelled estimated?

Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Vuity / Pilocarpine HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on brand name.

Why does this page start at 1 mL?

None of this product’s NDCs is in the FDA NDC Directory, so OpenBill cannot read how much one package holds. So the card starts at 1 ML; change it to match your prescription.

VUITY 1.25% EYE DROP

For 1 mL

Pharmacies pay

$23.39 – $31.39 filed

1 × $23.39475 to $31.3936 per ML (the 3 NDCs differ)

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$28.53 filed

1 × $28.53064 per ML, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

The spread

0.91× – 1.2× estimated

Medicare paid between 0.91× and 1.2× what pharmacies pay, depending on the NDC.

Part D averages every strength and form sold under “Vuity” / “Pilocarpine HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$31.90 – $41.10 estimated

NADAC for the pack + 15% + $5.00 fee per fill

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

VUITY 1.25% EYE DROP is how the CMS NADAC file names this product. The FDA NDC Directory does not list any of its NDCs as a package of its own, so OpenBill has no FDA names, dosage form or pharmacologic class for it.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes).

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $23.39 – $31.39 for 1 mL, depending on the NDC ($23.39475 to $31.3936 per ML), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

NADAC also lists, on the row of its brand NDCs, what pharmacies pay for the generic equivalent, a different product: $19.39133 to $24.74 per ML filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What NADAC measures · NADAC explanation codes

All 3 NDCs

00074-7098-02 · not listed as a package in the FDA directory · $31.3936 per ML · eff. 2026-09-23 filed
00074-7098-04 · not listed as a package in the FDA directory · $31.3936 per ML · eff. 2026-09-23 filed
00074-7098-06 · not listed as a package in the FDA directory · $23.39475 per ML · eff. 2026-09-23 filed

What Medicare paid

Medicare Part D paid $28.53 for 1 mL, at an average of $28.53064 per ML in 2024 (2024-01-01 to 2024-12-31) for “Vuity” and “Pilocarpine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 2,220 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

What is your cash price for 1 mL? Is it lower than what I would pay through my insurance?
Which NDC (the 11-digit number on the package) is this? Pharmacies pay $23.39475 to $31.3936 per ML for this product, depending on the NDC.
How much is in the package I am getting? This page uses 1 mL; your package may hold a different amount.
If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.

Questions

Why is the comparison with Medicare for VUITY 1.25% EYE DROP labelled estimated?: Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Vuity / Pilocarpine HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on brand name.
Why does this page start at 1 mL?: None of this product’s NDCs is in the FDA NDC Directory, so OpenBill cannot read how much one package holds. So the card starts at 1 ML; change it to match your prescription.